Navigation Links
Questcor Reports Third Quarter Financial Results
Date:10/25/2011

ANAHEIM, Calif., Oct. 25, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today reported record net sales of $59.8 million for its third quarter ended September 30, 2011, a 91% increase from $31.3 million in the year ago quarter.  Net income for the quarter was up 98% from the year ago quarter to $22.9 million or $0.35 per diluted share.

A 174% year-over-year increase in the number of paid H.P. Acthar® Gel (Acthar) prescriptions for the treatment of multiple sclerosis (MS) exacerbations led to increased shipments of Acthar vials.  Paid Acthar prescriptions for the treatment of nephrotic syndrome (NS) increased to 60 during the quarter, up from 45 in the second quarter and eight in the third quarter of 2010.  In addition, at 112, paid Acthar prescriptions for the treatment of infantile spasms (IS) were at the highest quarterly level since the third quarter of 2008.

"Questcor's strategy to sell more Acthar continues to generate increasing net sales and earnings," said Don M. Bailey, President and CEO of Questcor.  "Our commercial organization is steadily expanding the number of neurologists, nephrologists, and child neurologists prescribing Acthar.  We believe Acthar has the potential to benefit many more MS, NS, IS and possibly lupus patients in the future."

"Our 77 person Specialty Sales Force continues to drive expanded usage of Acthar as second-line therapy for MS exacerbations, a key Acthar market," commented Steve Cartt, Executive Vice President and Chief Business Officer. "Furthermore, during the third quarter we completed the expansion of our Nephrology Sales Force from 5 to 28 representatives, with all new personnel being fully trained and making initial sales calls by October 1st.  Despite the inherent disruption involved with this expansion, paid nephrotic syndrome Acthar prescriptions increased duri
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Questcor to Report Third Quarter 2011 Earnings and Conduct Conference Call on October 25, 2011
2. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for Third Quarter 2011
3. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on September 28, 2011
4. Questcor Provides Updated New Paid Prescription Trends
5. UPDATING and ADDING: Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
6. Questcor Pharmaceuticals to Present at the Canaccord Genuity Growth Conference on August 11, 2011
7. Questcor to Report Second Quarter 2011 Earnings and Conduct Conference Call on July 26, 2011
8. Questcor Proxy Proposals All Approved at 2011 Shareholder Meeting
9. Questcor Discusses ISS Proxy Recommendations; Provides Business Update
10. Questcor to Report First Quarter 2011 Earnings and Conduct Conference Call on April 26, 2011
11. Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... and HERZLIYA PITUACH, Israel, Nov. 25, 2014 ... or "the Company"), a clinical stage biopharmaceutical company ... targeted therapeutics for the treatment of inflammatory diseases ... previously announced underwritten public offering of 3,450,000 units, ... the Company,s common stock, par value $0.0001 per ...
(Date:11/24/2014)... -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today that ... update at the Piper Jaffray 26 th Annual Healthcare ... Time (5:30 a.m. Pacific Time), at The New York Palace ... A live audio webcast of the presentation will be available ... www.arenapharm.com . A replay of the presentation will be available ...
(Date:11/24/2014)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... today that Sergio Traversa , chief executive officer, ... Event" Micro-Cap Growth Conference on Wednesday, December 3, 2014.  ... Bel Air Hotel, which is located at 11461 Sunset ... The presentation is scheduled for 8:30 a.m. ...
Breaking Medicine Technology:Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Relmada Therapeutics To Present At LD MICRO Conference 2
... , MISSISSAUGA, Ontario, Dec. 30 ... Holdings Inc. (OTC Bulletin Board: CGNH), a developer of ... IVD testing market, was interviewed in MedTech Executive. ... for developing its QL Care Analyzer device, the FDA ...
... , BOSTON, Dec. 30 Solos Endoscopy, ... looks forward to a prosperous 2010, following a solid year in ... , In the closing months of 2009, Solos Endoscopy, Inc. has ... MammoView(TM) line of surgical endoscopy instruments. This will allow the MammoView(TM) ...
Cached Medicine Technology:Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive 2Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive 3Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive 4Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010 2
(Date:11/26/2014)... the video interviewing specialist, has today announced the appointment ... Officer, in addition to the formal opening of it’s ... appointed as Chief Operating Officer. He is joined by ... Officer. , Mr Jones is a seasoned tech, media ... with The Walt Disney Company and Adventis where he ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Anthropologists ... effectiveness in containing and stopping Ebola, improve international ... in healthcare systems in West Africa. , ... to Stop Ebola: Anthropologists Offer Insights,” will be ... the American Anthropological Association (AAA), Fri., Dec. 5, ...
(Date:11/26/2014)... Medical suction and vacuum products have a ... score represents steady growth in the price of medical ... a result of swelling demand for healthcare services and ... considered nondiscretionary. IBISWorld market research analyst, Anna Son, says, ... of flexibility, given the low level of price volatility ...
(Date:11/26/2014)... For those with a New Year’s resolution to ... classes at the University of Colorado Anschutz Health and ... for. The 45- 60 minute classes have just started and ... fitness club memberships. , LES MILLS BODYPUMP™ exercise classes strengthen, ... aimed at fast results , By focusing on low ...
(Date:11/26/2014)... November 26, 2014 News Facts ... expanded capabilities at RSNA 2014 in Chicago. The ... and share diagnostic images, photos, videos and documents ... booth #8107 will learn more about these innovative ... technologies and partner initiatives – that enable more ...
Breaking Medicine News(10 mins):Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3
... to Accelerate Adoption, WASHINGTON, Dec. 5 ... improve health care through electronic prescribing (e-prescribing), ... bipartisan,legislation introduced by Senate Finance Committee Members ... (D-Mich.), Senator Mel,Martinez (R-Fla.), and endorsed by ...
... Two studies support efforts to reduce air pollution, especially ... Two real-world studies from Europe demonstrate the health damage ... by diesel engines. , An 11-year period of improving ... the cleanest air in Europe, produced measurable benefits in ...
... portfolio, SHAWNEE, Kan., Dec. 5 AVP ... industry, will change its name to Avascend,effective December ... brand is the,expanded service portfolio and the same ... Avascend currently provides the following core healthcare hospitality,services: ...
... lifestyle drives new store openings, PITTSBURGH, Dec. 5 ... resolution or two. For GNC, it means more new ... expected to rise steadily,through 2012, according to the Nutrition ... once again expand its store base and overall,business: The ...
... DND, MISSISSAUGA, ON, Dec. 5 /PRNewswire-FirstCall/ - ... Stefan Aigner, M.D., CFA, has been,appointed to its ... than 20 years of experience in the global,healthcare ... Business,Development for Alpharma, Inc. (NYSE: ALO ), ...
... Ventas, Inc. (NYSE:,VTR) ("Ventas" or the ... of its Board of Directors has granted ... to encourage their,long-term retention and reward performance. ... the Company,s Chief Investment Officer, Richard A.,Schweinhart, ...
Cached Medicine News:Health News:PCMA Supports Bipartisan Legislation Calling for E-Prescribing Requirement in Medicare 2Health News:Cleaner Air Leads to Healthier Lungs 2Health News:Cleaner Air Leads to Healthier Lungs 3Health News:AVP is Now Avascend 2Health News:GNC Franchising Expected to Grow Through 2008 2Health News:Cipher appoints Stefan Aigner to board of directors 2Health News:Cipher appoints Stefan Aigner to board of directors 3Health News:Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance 2Health News:Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance 3Health News:Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance 4
Micro-Kerrison Laminectomie Rongeur and Stella Punch, golden springs, with ejector. 18 cm - 7 1/8, very delicate, narrow footplate, small handle, 40 up-cutting, jaws 2 mm wide....
Kerrison (Micro) Laminectomy rongeur with ejector. 18 cm - 7 1/8, thick footplate, small handle, very delicate, 40 up-cutting, jaws 2 mm wide....
... The Tangent Posterior Impacted Instrument Set offers ... of the advantages offered by the Tangent ... preparation and the ability to reproduce the ... to ensure proper vertebral body distraction. A ...
... ValveTM, Hakim, H-V Lumbar Valve ... for meeting the complex demands ... response causes the valve to ... present, eliminating the need for ...
Medicine Products: